Claritas Pharmaceuticals (KALTF) Stock Price, News & Analysis

Company Overview

Claritas Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing therapies for serious and potentially life-threatening diseases. The company’s work has centered on novel drug candidates intended to address unmet needs in areas including infectious disease, inflammation and respiratory conditions.

Claritas’ lead development program has involved R-107, an oral, controlled-release nitric oxide donor. The candidate has been evaluated for its potential use in COVID-19 and related respiratory complications, although the company’s product candidates remain subject to clinical testing and regulatory review and are not necessarily approved for commercial use.

The company was formerly known as Kalytera Therapeutics Inc. and adopted the Claritas Pharmaceuticals name as it repositioned its business toward pharmaceutical drug development. Publicly available information about its current operations, geographic reach and leadership is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 9,705 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/29/2013
• Today: 10/29/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:KALTF
• Previous Symbol: OTCMKTS:QUEZF
• CIK: N/A
• Web: kalytera.co
• Phone: (888) 861-2008
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A